N/A
N=30
Comparison of Sleep Study Results After Partial Intracapsular Tonsillectomy Versus Total Tonsillectomy
Sleep-disordered Breathing · Obstructive Sleep Apnea
Bottom Line
View on ClinicalTrials.gov: NCT00887471 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Feb 2014
Primary outcome: Primary: Median Change in Apnea-hypopnea Index (AHI) — 3.8; 8.0 events per hour of sleep — p=.590
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- PITA or T&A (Procedure)
- Age
- Pediatric · 0+ yrs
- Sex
- All
- Sponsor
- State University of New York - Downstate Medical Center
- Primary completion
- Oct 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Median Change in Apnea-hypopnea Index (AHI) |
3.8; 8.0 | .590 |
| SECONDARY Number of Patients With Apnea-hypopnea Index (AHI) Less Than or Equal to 5 |
5; 4 | 1.00 |
Summary
The purpose of this study is to demonstrate similar improvements in sleep-disordered breathing as determined by sleep study with microdebrider-assisted partial intracapsular tonsillectomy and adenoidectomy versus total Bovie electrocautery tonsillectomy and adenoidectomy.
Eligibility Criteria
Inclusion Criteria
- The medical records of 149 children who underwent partial intracapsular tonsillectomy and adenoidectomy at the State University of New York (SUNY) Downstate Medical Center or the Long Island College Hospital will be reviewed to identify children with positive preoperative polysomnography. 18 of those with positive preoperative studies will be randomly selected and offered participation in the study.
- Once enrolled, the participants will be matched by age, sex, time since procedure and polysomnography results (Apnea Hypopnea Index Index within 5) to 18 children who underwent traditional tonsillectomy and adenoidectomy (out of a total of 455 patients).
Exclusion Criteria
- Recurrent tonsillitis
- Craniofacial syndromes
- Neuromuscular disorders
- Sickle cell disease
Data sourced from ClinicalTrials.gov (NCT00887471). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.